Bnp Paribas Asset Management Holding S.A. Axogen, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Axogen, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 449 shares of AXGN stock, worth $6,241. This represents 0.0% of its overall portfolio holdings.
Number of Shares
449Holding current value
$6,241% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXGN
# of Institutions
189Shares Held
39.8MCall Options Held
61.7KPut Options Held
42.8K-
First Light Asset Management, LLC Edina, MN4.47MShares$62.2 Million10.62% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$45.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.6MShares$36.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$35.3 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.59MShares$22.1 Million0.54% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $588M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...